Actively Recruiting
Recovery in Telling Life Stories
Led by University of Aarhus · Updated on 2025-08-14
20
Participants Needed
1
Research Sites
88 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project tests the Recovery In Telling Life Stories (RETELL) intervention, aimed at supporting personal recovery in people with severe mental illness (SMI). While many of those with SMI experience symptom control, their quality of life often remains low due to social loss, negative self-perceptions, and identity-related challenges not addressed by standard treatments. Through a process of narrative repair, the RETELL intervention helps participants explore the personal consequences of mental illness while supporting the enhancement of narratives that strengthen identity and foster well-being. The intervention is delivered across 8-12 sessions and will be assessed for feasibility of both the intervention and study procedures. We will also explore its preliminary impact on recovery, quality of life, symptoms, functioning, self-stigma, and personality, using a multiple single-case A-B-A design. We expect the intervention and study procedures to show acceptable feasibility. We further hypothesize that participants' scores on recovery and well-being will be low at baseline, improve during the intervention, and remain higher after the intervention ends and at 3-month follow-up. This study will provide a foundation for future randomized controlled trials.
CONDITIONS
Official Title
Recovery in Telling Life Stories
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults between the ages of 18 and 65 years
- Self-reported diagnosis of schizophrenia, bipolar disorder, personality disorders, obsessive-compulsive disorder, anxiety disorders, recurrent depressive disorder, eating disorders, hyperkinetic disorders, post-traumatic stress disorder, or Asperger syndrome
- Not in full recovery (Brief INSPIRE-O score less than 50)
- Proficient in Danish language
- Medication stabilized with same type and dosage for at least 8 weeks
- Able and willing to give informed consent
You will not qualify if you...
- Self-reported diagnosis of mental retardation or organic mental disorder
- Psychiatric symptoms, thoughts of self-harm, or substance abuse severe enough to prevent attendance, questionnaire completion, or meaningful therapy participation
- Psychiatric hospitalization within the past 4 weeks
- Prior conviction of violent crime
- Currently homeless
- Receiving psychotherapy started within the past 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aarhus Univerity
Aarhus C, Denmark, 8000
Actively Recruiting
Research Team
D
Dinne S. Christensen, PhD
CONTACT
D
Dorthe K. Thomsen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here